Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up - Top-Institutions - MDSpire

Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up

  • By

  • B. Boeer

  • J. Kandzi

  • B. Schoenfisch

  • M. Marx

  • S. Guergan

  • I. Gruber

  • C. Roehm

  • G. Helms

  • A. Hartkopf

  • S. Y. Brucker

  • M. Hahn

  • April 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Surgical Oncology
    • Plastic and Reconstructive Surgery
    • Psycho-oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Surgical Oncology
    • Plastic Surgery
    • Quality of Life Research

  • #3

    Dana-Farber/Brigham and Women’s Cancer Center
    Dana-Farber/Brigham and Women’s Cancer Center

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Plastic and Reconstructive Surgery
    • Patient-Reported Outcomes

  • #4

    University of Tuebingen, Department of Women’s Health
    University of Tuebingen, Department of Women’s Health

    Tuebingen, Baden-Württemberg

    Key Differentiators

    • Breast Surgery
    • Oncoplastic Surgery
    • Quality of Life Research

  • #5

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Breast Surgical Oncology
    • Plastic Surgery
    • Outcomes Research

Original Source(s)

Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up

  • by B. Boeer, J. Kandzi, B. Schoenfisch, M. Marx, S. Guergan, I. Gruber, C. Roehm, G. Helms, A. Hartkopf, S. Y. Brucker, M. Hahn

  • April 7, 2026

Related Content

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models

Diagnosis and treatment of breast cancer metastasis to thyroid: a case report and literature review